ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,615.35
0.55%
US Tech 100
19,804.00
0.64%
Dow Jones
40,000.90
0.62%
Brent Oil
84.57
0.00%
Bitcoin
60,101.31
1.46%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aevi Genomic Medicine Inc (GNMX)

  7. Aevi Genomic Medicine Inc (GNMX) News

GNMX

Aevi Genomic Medicine (GNMX)

Aevi Genomic Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GNMX
DateTimeSourceHeadlineSymbolCompany
07/02/20129:35AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:GNMXAevi Genomic Medicine Inc
06/25/20126:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
06/22/201212:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
06/20/201211:31AMBusiness WireMedgenics Receives Orphan Drug Designation from FDA for INFRADURE Biopump to Treat Hepatitis DNASDAQ:GNMXAevi Genomic Medicine Inc
06/19/20129:34AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:GNMXAevi Genomic Medicine Inc
06/19/20129:25AMBusiness WireMedgenics, Inc. Raises $9.5 Million in Private PlacementNASDAQ:GNMXAevi Genomic Medicine Inc
06/07/201210:30AMBusiness WireMedgenics Initiates U.S. Biopump Processing SiteNASDAQ:GNMXAevi Genomic Medicine Inc
05/18/201210:00AMBusiness WireMedgenics to Present at the 11th Annual ILSI BIOMED 2012NASDAQ:GNMXAevi Genomic Medicine Inc
05/17/201210:00AMBusiness WireMedgenics Receives FDA Clearance to Commence Phase IIb Trial of EPODURE for Sustained Anemia Treatment in Dialysis PatientsNASDAQ:GNMXAevi Genomic Medicine Inc
05/14/20121:00PMBusiness WireMedgenics Announces First Quarter 2012 Financial ResultsNASDAQ:GNMXAevi Genomic Medicine Inc
05/14/201212:35PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:GNMXAevi Genomic Medicine Inc
05/09/201210:00AMBusiness WireMedgenics Awarded $2.2 Million Grant from the Israeli Office of the Chief ScientistNASDAQ:GNMXAevi Genomic Medicine Inc
04/26/20122:43PMBusiness WireMedgenics Comments on Market Trading ActivityNASDAQ:GNMXAevi Genomic Medicine Inc
04/18/20125:00PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:GNMXAevi Genomic Medicine Inc
04/17/201210:15AMBusiness WireMedgenics Files IND Application for EPODURE Biopump Phase IIb Anemia Study in Dialysis PatientsNASDAQ:GNMXAevi Genomic Medicine Inc
04/05/20121:11PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:GNMXAevi Genomic Medicine Inc
04/05/201211:15AMBusiness WireMedgenics Announces Results of 2012 Annual Meeting of StockholdersNASDAQ:GNMXAevi Genomic Medicine Inc
03/26/201210:00AMBusiness WireMedgenics Reports Positive Meeting With NIH Recombinant DNA Advisory CommitteeNASDAQ:GNMXAevi Genomic Medicine Inc
03/23/201210:00AMBusiness WireMedgenics Cleared to Initiate Phase IIa Anemia Study of EPODURE Biopump in Dialysis Patients in IsraelNASDAQ:GNMXAevi Genomic Medicine Inc
03/21/201210:00AMBusiness WireMedgenics to Present at the Maxim Group Growth ConferenceNASDAQ:GNMXAevi Genomic Medicine Inc
03/13/20123:00AMBusiness WireMedgenics Announces Participation in Roth Conference and Other MattersNASDAQ:GNMXAevi Genomic Medicine Inc
03/09/201211:03AMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:GNMXAevi Genomic Medicine Inc
03/06/20129:37AMEdgar (US Regulatory)Annual Report (10-K)NASDAQ:GNMXAevi Genomic Medicine Inc
03/01/20127:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/28/20121:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/28/20121:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/28/20121:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/28/20121:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/28/20121:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
02/28/20121:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:GNMX

Your Recent History

COIN
XRPUSD
Ripple
USOTC
MVNT
Movement Industries (PK)
USOTC
GRST
Ethema Health (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
ERHE
ERHC Energy (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
IQST
iQSTEL (QX)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
RDGL
Vivos (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
FNMA
Fannie Mae (QB)
USOTC
AABB
Asia Broadband (PK)
USOTC
BIEL
Bioelectronics (PK)
NASDAQ
COOP
Mr Cooper
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved